Viral therapy tested to fight skin cancer in vulnerable transplant patients
NCT ID NCT04349436
Summary
This study is testing an experimental therapy called RP1 for people who have had an organ or bone marrow transplant and now have advanced skin cancer. RP1 is a modified cold sore virus that is injected directly into tumors to try to destroy them and boost the body's immune response against the cancer. The main goals are to see if the treatment is safe for people with transplants and if it can shrink or control their skin cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Medical Center
WITHDRAWNNew York, New York, 10032, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Duke University
RECRUITINGDurham, North Carolina, 27708, United States
Contact
-
Inova Schar Cancer Institute
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Mayo Clinic Arizona
RECRUITINGPhoenix, Arizona, 85054, United States
Contact Phone: •••-•••-••••
Contact
-
Mayo Clinic Florida
RECRUITINGJacksonville, Florida, 32224, United States
Contact Phone: •••-•••-••••
Contact
-
Mayo Clinic Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-••••
-
Medical Dermatology Specialists
RECRUITINGPhoenix, Arizona, 85006, United States
Contact
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact
-
Rochester Dermatologic Surgery
RECRUITINGNew York, New York, 14564, United States
Contact
-
The Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
Contact
-
The Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
-
UCSF, Helen Diller Family Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94143, United States
Contact
-
University of California, Los Angeles
RECRUITINGLos Angeles, California, 90024, United States
Contact
-
University of California, San Diego
RECRUITINGLa Jolla, California, 92093, United States
Contact
-
University of Chicago
WITHDRAWNChicago, Illinois, 60637, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45267, United States
Contact
-
University of Colorado Cancer Center School of Medicine
RECRUITINGAurora, Colorado, 80045, United States
Contact
-
University of Miami Sylvester Comprehensive Cancer Center
RECRUITINGMiami, Florida, 33136, United States
Contact
-
University of Michigan
WITHDRAWNAnn Arbor, Michigan, 48109, United States
-
University of North Carolina Lineberger Comprehensive Cancer Center
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact
-
University of Tennessee Medical Center at Knoxville
RECRUITINGKnoxville, Tennessee, 37920, United States
Contact
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75235, United States
Contact
-
VCU Massey Cancer Center
WITHDRAWNRichmond, Virginia, 23298, United States
-
Washington University in St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Conditions
Explore the condition pages connected to this study.